drugset / Trial / NCT00452829

Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)

NCT00452829

Phase 1 Completed 100 enrolled Institute of Child Health
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of the study is to develop a randomised, double blind clinical trial to compare (i) folic acid plus inositol, with (ii) folic acid plus placebo, for prevention of recurrent neural tube defects.

Timeline

Start
2009-09
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Inositol Small molecule 1 g
Background folic acid Other / unclassified 5 mg

Indications